PATENT CLAIM ANALYSIS

Application Number: 15936169
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "325000"]

Abstract:
The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment thereof.

Claim (Index 21):
The nucleic acid molecule of  claim 20 , wherein the non-cat TERT antigenic fragment originates from a dog TERT sequence.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.15385
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14780613', '14780652', '15032966', '11974067', '11826134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.694316173006079
- 35 USC 102 Novelty (BERT): 0.6059604125333539
- Combined Prediction Score: 0.6854805969588065
- Mean Citation Score: 425.556528
- Max Citation Score: 634.4167
- Similarity Product: 459.8414783290148

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test